查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1595388

血漿治療市場：按類型、按應用分類 - 2025-2030 年全球預測

Plasma Therapy Market by Type (Leucocyte-rich PRP, Leukocyte-rich Fibrin (L-PRF), Pure Platelet-rich Fibrin (PRF)), Application (Dental, Dermatology, Nerve Injury) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年血漿治療市值為3.5973億美元，預計2024年將達到3.8919億美元，複合年成長率為11.73%，到2030年將達到7.8195億美元。

血漿治療，特別是在恢復期血漿治療的情況下，涉及輸入從感染疾病中康復的個體的血漿。血漿治療的範圍也擴展到使用血漿中存在的中和抗體來治療病毒感染疾病。當發生沒有特定治療方法或疫苗的疾病時，這一點尤其重要。應用包括恢復期、免疫球蛋白治療和治療性血漿置換，最終用途主要在醫院、學術研究機構和治療中心。該市場的推動因素是自體免疫疾病的盛行率不斷上升，以及對改善針對危及生命的病毒感染疾病（如 COVID-19）的治療方法的日益成長的需求。此外，人口老化將導致血漿捐贈者持續湧入，推動市場擴張。研究和技術的進步帶來了新的市場機會，並推動血漿採集和儲存技術的創新，以提高功效和安全性。然而，市場面臨重大挑戰，包括監管不確定性、輸血感染疾病的風險以及平衡血漿供需方面的後勤障礙。治療的標準化也是一個主要障礙，它可能導致治療結果的改變。該市場開拓包括開發用於高效血漿分離和處理的自動化設備。研究還可以針對基因工程來提高血漿的有效性。學術、臨床和工業相關人員之間的合作可以加速新協議的開發和新血漿用例的識別。這些努力將促進市場競爭並擴大治療選擇。因此，市場動態是動態的，潛在的成長受到後勤和監管複雜性的限制。對創新和策略夥伴關係的關注可以為克服這些障礙並開拓新的成長機會指明道路。

主要市場統計
基準年[2023] 3.5973億美元
預測年份 [2024] 3.8919 億美元
預測年份 [2030] 78195萬美元
複合年成長率（%） 11.73%

市場動態：快速發展的血漿治療市場的關鍵市場洞察

供需的動態交互作用正在改變血漿治療市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 全球感染疾病與慢性病流行
    • 傾向於疾病的早期診斷和治療
    • 檢驗血漿療法有效性的臨床試驗增加
  • 市場限制因素
    • 血漿療法治療成本上升
  • 市場機會
    • 富血小板血漿治療的進展
    • 血漿療法在皮膚科的新用途
  • 市場挑戰
    • 與血漿治療相關的副作用

波特五力：駕馭血漿治療市場的策略工具

波特的五力框架是了解血漿治療市場競爭格局的關鍵工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢、解決弱點並避免潛在的挑戰，以確保更強大的市場地位。

PESTLE分析：了解血漿治療市場的外部影響

外部宏觀環境因素在塑造血漿治療市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解血漿治療市場的競爭格局

對血漿治療市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位基質血漿治療市場供應商績效評估

FPNV定位矩陣是評估血漿治療市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議，規劃血漿治療市場的成功之路

血漿治療市場的策略分析對於旨在加強其在全球市場的影響力的公司至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 世界各地感染疾病和慢性病的流行情況
      • 疾病的早​​期診斷和治療趨勢
      • 增加臨床試驗來測試血漿療法的有效性
    • 抑制因素
      • 血漿療法治療費用高
    • 機會
      • 血小板富集血漿療法的進展
      • 血漿療法在皮膚科的新用途
    • 任務
      • 與血漿治療相關的不良反應
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章 血漿治療市場：依類型

  • PRP含有大量白血球
  • 含白血球纖維蛋白 (L-PRF)
  • 純血小板纖維蛋白 (PRF)
  • 純PRP

第7章 血漿治療市場：依應用分類

  • 牙科
  • 皮膚科
  • 神經損傷
  • 整形外科

第8章美洲血漿治療市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太血漿治療市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章歐洲/中東/非洲血漿治療市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Abeona Therapeutics Inc.
  • ADMA Biologics, Inc.
  • Arthrex, Inc.
  • Bio Products Laboratory Ltd.
  • Biotest AG
  • China Biologic Products, Inc.
  • CSL Limited
  • Emergent BioSolutions Inc.
  • Exactech Inc.
  • GC Pharma
  • Global Stem Cells Group, Inc.
  • Green Cross Corporation
  • Grifols, SA
  • Hualan Biological Engineering Inc.
  • Interstate Blood Bank, Inc.
  • Japan Blood Products Organization
  • Johnson & Johnson Services, Inc.
  • Kedrion SpA
  • LFB SA
  • Octapharma AG
  • Regen Lab SA
  • Shanghai RAAS Blood Products Co., Ltd.
  • Stryker Corporation
  • Takeda Pharmaceutical Company Limited
  • Terumo Corporation
  • Zimmer Biomet Holdings, Inc
Product Code: MRR-DD0700E81E9A

The Plasma Therapy Market was valued at USD 359.73 million in 2023, expected to reach USD 389.19 million in 2024, and is projected to grow at a CAGR of 11.73%, to USD 781.95 million by 2030.

Plasma therapy, especially in the context of convalescent plasma therapy, involves the transfusion of plasma from individuals who have recovered from infections. The scope of plasma therapy extends to its application in treating viral infections by utilizing neutralizing antibodies present in the plasma. It is a crucial therapeutic tool, particularly for disease outbreaks where specific treatments or vaccines are unavailable. The application spans convalescent plasma therapy, immunoglobulin therapy, and therapeutic plasma exchange, with end-use mainly in hospitals, academic research institutes, and therapeutic centers. The market is driven by rising incidences of autoimmune diseases and the increased necessity for improved treatments for life-threatening viral infections like COVID-19. Additionally, the aging population presents a continuous influx of plasma donors, thereby facilitating market expansion. Advancements in research and technology promise new market opportunities, inviting innovation in plasma collection and storage techniques to enhance efficacy and safety. However, the market faces substantial challenges such as regulatory uncertainties, risks of transfusion-transmitted infections, and logistical hurdles in plasma supply and demand balance. A significant barrier remains the standardization of therapies, which can lead to varied treatment outcomes. Innovating within this market could involve developing automated devices for efficient plasma separation and processing. Research could also target genetic engineering to enhance plasma efficacy. Collaborations across academic, clinical, and industry stakeholders could accelerate the development of new protocols and the identification of novel plasma-use-cases. These efforts will drive market competitiveness and broaden therapeutic options. The plasma therapy market is thus dynamic, with potential growth tempered by logistical and regulatory complexities. Emphasizing innovation and strategic partnerships can provide a pathway to overcoming these barriers and exploiting new growth opportunities.

KEY MARKET STATISTICS
Base Year [2023] USD 359.73 million
Estimated Year [2024] USD 389.19 million
Forecast Year [2030] USD 781.95 million
CAGR (%) 11.73%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Plasma Therapy Market

The Plasma Therapy Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Prevalence of infectious and chronic diseases worldwide
    • Inclination towards early diagnosis and treatment of diseases
    • Increase in number of clinical trials to test efficacy of plasma therapy
  • Market Restraints
    • High cost of plasma therapy treatment
  • Market Opportunities
    • Advancements in platelet-rich plasma therapy
    • Emerging use of plasma therapy in dermatology
  • Market Challenges
    • Adverse effects associated with the plasma therapy

Porter's Five Forces: A Strategic Tool for Navigating the Plasma Therapy Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Plasma Therapy Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Plasma Therapy Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Plasma Therapy Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Plasma Therapy Market

A detailed market share analysis in the Plasma Therapy Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Plasma Therapy Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Plasma Therapy Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Plasma Therapy Market

A strategic analysis of the Plasma Therapy Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Plasma Therapy Market, highlighting leading vendors and their innovative profiles. These include Abeona Therapeutics Inc., ADMA Biologics, Inc., Arthrex, Inc., Bio Products Laboratory Ltd., Biotest AG, China Biologic Products, Inc., CSL Limited, Emergent BioSolutions Inc., Exactech Inc., GC Pharma, Global Stem Cells Group, Inc., Green Cross Corporation, Grifols, S.A., Hualan Biological Engineering Inc., Interstate Blood Bank, Inc., Japan Blood Products Organization, Johnson & Johnson Services, Inc., Kedrion S.p.A., LFB S.A., Octapharma AG, Regen Lab SA, Shanghai RAAS Blood Products Co., Ltd., Stryker Corporation, Takeda Pharmaceutical Company Limited, Terumo Corporation, and Zimmer Biomet Holdings, Inc.

Market Segmentation & Coverage

This research report categorizes the Plasma Therapy Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Leucocyte-rich PRP, Leukocyte-rich Fibrin (L-PRF), Pure Platelet-rich Fibrin (PRF), and Pure PRP.
  • Based on Application, market is studied across Dental, Dermatology, Nerve Injury, and Orthopedics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Prevalence of infectious and chronic diseases worldwide
      • 5.1.1.2. Inclination towards early diagnosis and treatment of diseases
      • 5.1.1.3. Increase in number of clinical trials to test efficacy of plasma therapy
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of plasma therapy treatment
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancements in platelet-rich plasma therapy
      • 5.1.3.2. Emerging use of plasma therapy in dermatology
    • 5.1.4. Challenges
      • 5.1.4.1. Adverse effects associated with the plasma therapy
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Plasma Therapy Market, by Type

  • 6.1. Introduction
  • 6.2. Leucocyte-rich PRP
  • 6.3. Leukocyte-rich Fibrin (L-PRF)
  • 6.4. Pure Platelet-rich Fibrin (PRF)
  • 6.5. Pure PRP

7. Plasma Therapy Market, by Application

  • 7.1. Introduction
  • 7.2. Dental
  • 7.3. Dermatology
  • 7.4. Nerve Injury
  • 7.5. Orthopedics

8. Americas Plasma Therapy Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Plasma Therapy Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Plasma Therapy Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abeona Therapeutics Inc.
  • 2. ADMA Biologics, Inc.
  • 3. Arthrex, Inc.
  • 4. Bio Products Laboratory Ltd.
  • 5. Biotest AG
  • 6. China Biologic Products, Inc.
  • 7. CSL Limited
  • 8. Emergent BioSolutions Inc.
  • 9. Exactech Inc.
  • 10. GC Pharma
  • 11. Global Stem Cells Group, Inc.
  • 12. Green Cross Corporation
  • 13. Grifols, S.A.
  • 14. Hualan Biological Engineering Inc.
  • 15. Interstate Blood Bank, Inc.
  • 16. Japan Blood Products Organization
  • 17. Johnson & Johnson Services, Inc.
  • 18. Kedrion S.p.A.
  • 19. LFB S.A.
  • 20. Octapharma AG
  • 21. Regen Lab SA
  • 22. Shanghai RAAS Blood Products Co., Ltd.
  • 23. Stryker Corporation
  • 24. Takeda Pharmaceutical Company Limited
  • 25. Terumo Corporation
  • 26. Zimmer Biomet Holdings, Inc

LIST OF FIGURES

  • FIGURE 1. PLASMA THERAPY MARKET RESEARCH PROCESS
  • FIGURE 2. PLASMA THERAPY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL PLASMA THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL PLASMA THERAPY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL PLASMA THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL PLASMA THERAPY MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL PLASMA THERAPY MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS PLASMA THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS PLASMA THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES PLASMA THERAPY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES PLASMA THERAPY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC PLASMA THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC PLASMA THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA PLASMA THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA PLASMA THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. PLASMA THERAPY MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. PLASMA THERAPY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. PLASMA THERAPY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL PLASMA THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL PLASMA THERAPY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL PLASMA THERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. PLASMA THERAPY MARKET DYNAMICS
  • TABLE 7. GLOBAL PLASMA THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL PLASMA THERAPY MARKET SIZE, BY LEUCOCYTE-RICH PRP, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL PLASMA THERAPY MARKET SIZE, BY LEUKOCYTE-RICH FIBRIN (L-PRF), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL PLASMA THERAPY MARKET SIZE, BY PURE PLATELET-RICH FIBRIN (PRF), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL PLASMA THERAPY MARKET SIZE, BY PURE PRP, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL PLASMA THERAPY MARKET SIZE, BY DENTAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL PLASMA THERAPY MARKET SIZE, BY DERMATOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL PLASMA THERAPY MARKET SIZE, BY NERVE INJURY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL PLASMA THERAPY MARKET SIZE, BY ORTHOPEDICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS PLASMA THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS PLASMA THERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 20. ARGENTINA PLASMA THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 21. ARGENTINA PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 22. BRAZIL PLASMA THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. BRAZIL PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 24. CANADA PLASMA THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. CANADA PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. MEXICO PLASMA THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. MEXICO PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. UNITED STATES PLASMA THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. UNITED STATES PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. UNITED STATES PLASMA THERAPY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 31. ASIA-PACIFIC PLASMA THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. ASIA-PACIFIC PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. ASIA-PACIFIC PLASMA THERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 34. AUSTRALIA PLASMA THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. AUSTRALIA PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. CHINA PLASMA THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. CHINA PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. INDIA PLASMA THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. INDIA PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. INDONESIA PLASMA THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. INDONESIA PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. JAPAN PLASMA THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. JAPAN PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. MALAYSIA PLASMA THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. MALAYSIA PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. PHILIPPINES PLASMA THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. PHILIPPINES PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. SINGAPORE PLASMA THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. SINGAPORE PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. SOUTH KOREA PLASMA THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. SOUTH KOREA PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. TAIWAN PLASMA THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. TAIWAN PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. THAILAND PLASMA THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. THAILAND PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. VIETNAM PLASMA THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. VIETNAM PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. EUROPE, MIDDLE EAST & AFRICA PLASMA THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. EUROPE, MIDDLE EAST & AFRICA PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. EUROPE, MIDDLE EAST & AFRICA PLASMA THERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 61. DENMARK PLASMA THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. DENMARK PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. EGYPT PLASMA THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. EGYPT PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. FINLAND PLASMA THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. FINLAND PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. FRANCE PLASMA THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. FRANCE PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. GERMANY PLASMA THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. GERMANY PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. ISRAEL PLASMA THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. ISRAEL PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. ITALY PLASMA THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. ITALY PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. NETHERLANDS PLASMA THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. NETHERLANDS PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. NIGERIA PLASMA THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. NIGERIA PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. NORWAY PLASMA THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. NORWAY PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. POLAND PLASMA THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. POLAND PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. QATAR PLASMA THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. QATAR PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. RUSSIA PLASMA THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. RUSSIA PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. SAUDI ARABIA PLASMA THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. SAUDI ARABIA PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH AFRICA PLASMA THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH AFRICA PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. SPAIN PLASMA THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. SPAIN PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. SWEDEN PLASMA THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. SWEDEN PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. SWITZERLAND PLASMA THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. SWITZERLAND PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. TURKEY PLASMA THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. TURKEY PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED ARAB EMIRATES PLASMA THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED ARAB EMIRATES PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. UNITED KINGDOM PLASMA THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. UNITED KINGDOM PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. PLASMA THERAPY MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 104. PLASMA THERAPY MARKET, FPNV POSITIONING MATRIX, 2023